Wei Chen Selected Research

Hepatocellular Carcinoma (Hepatoma)

1/2024	Liquid-liquid phase separation-related lncRNA prognostic signature and ZNF32-AS2 as a novel biomarker in hepatocellular carcinoma.
1/2024	Fluorescence/electrochemical dual-mode strategy for Golgi protein 73 detection based on molybdenum disulfide/ferrocene/palladium nanoparticles and nitrogen-doped graphene quantum dots.
1/2024	Development and Validation of a Novel Nomogram Integrated with Hypoxic and Lactate Metabolic Characteristics for Prognosis Prediction in Hepatocellular Carcinoma.
12/2023	Overexpression of HMGB1 in hepatocytes accelerates PTEN inactivation-induced liver cancer.
11/2023	Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related Events.
11/2023	High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate.
11/2023	Predicting symptomatic post-hepatectomy liver failure in patients with hepatocellular carcinoma: development and validation of a preoperative nomogram.
10/2023	Cuproptosis-related signature for clinical prognosis and immunotherapy sensitivity in hepatocellular carcinoma.
6/2023	Single-cell analysis reveals HBV-specific PD-1+CD8+ TRM cells in tumor borders are associated with HBV-related hepatic damage and fibrosis in HCC patients.
5/2023	An exosome-related lncRNA signature correlates with prognosis, immune microenvironment, and therapeutic responses in hepatocellular carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei Chen Research Topics

Disease

1178	Neoplasms (Cancer) 07/2024 - 03/2002
333	Inflammation (Inflammations) 05/2024 - 01/2004
205	Neoplasm Metastasis (Metastasis) 05/2024 - 03/2005
205	Infections 05/2024 - 04/2003
142	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 08/2003
140	Breast Neoplasms (Breast Cancer) 05/2024 - 11/2002
110	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 06/2002
106	Fibrosis (Cirrhosis) 05/2024 - 03/2002
97	Obesity 03/2024 - 07/2002
94	Carcinogenesis 02/2024 - 01/2008
92	Carcinoma (Carcinomatosis) 04/2024 - 03/2002
91	Hypertension (High Blood Pressure) 04/2024 - 03/2002
90	Lung Neoplasms (Lung Cancer) 03/2024 - 04/2006
88	Hypoxia (Hypoxemia) 05/2024 - 01/2004
84	Wounds and Injuries (Trauma) 04/2024 - 01/2002
83	Insulin Resistance 10/2023 - 05/2003
81	COVID-19 12/2024 - 01/2020
79	Urinary Bladder Neoplasms (Bladder Cancer) 05/2024 - 04/2003
78	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 12/2004
70	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 01/2003
66	Stomach Neoplasms (Stomach Cancer) 05/2024 - 03/2003
65	Body Weight (Weight, Body) 07/2024 - 02/2005
65	Pain (Aches) 03/2024 - 07/2007
62	Type 2 Diabetes Mellitus (MODY) 06/2023 - 03/2003
59	Glioma (Gliomas) 12/2023 - 12/2004
57	Colitis 03/2024 - 06/2007
52	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 01/2004
51	Sepsis (Septicemia) 04/2024 - 11/2006
51	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 03/2008
50	Renal Cell Carcinoma (Grawitz Tumor) 03/2024 - 06/2008
50	Stroke (Strokes) 02/2024 - 08/2003
47	Ischemia 01/2024 - 01/2002
46	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 04/2005
45	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 08/2006
44	Myocardial Infarction 12/2024 - 06/2004
42	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2024 - 06/2005
42	Liver Cirrhosis (Hepatic Cirrhosis) 04/2024 - 05/2006
42	Colonic Neoplasms (Colon Cancer) 01/2024 - 05/2004
42	Pneumonia (Pneumonitis) 10/2023 - 03/2010
41	Asthma (Bronchial Asthma) 10/2023 - 03/2009
40	Hemorrhage 02/2024 - 01/2003
39	Atherosclerosis 05/2024 - 03/2004
38	Adenocarcinoma 02/2023 - 10/2007
37	Necrosis 02/2024 - 03/2005
34	Reperfusion Injury 04/2024 - 06/2003
34	Leukemia 02/2024 - 03/2002
33	Heart Failure 04/2024 - 04/2013

Drug/Important Bio-Agent (IBA)

382	Proteins (Proteins, Gene)FDA Link 04/2024 - 03/2002
264	Biomarkers (Surrogate Marker)IBA 05/2024 - 06/2005
150	CytokinesIBA 05/2024 - 11/2004
148	MicroRNAs (MicroRNA)IBA 04/2024 - 03/2007
125	Messenger RNA (mRNA)IBA 01/2024 - 01/2004
118	Long Noncoding RNAIBA 03/2024 - 03/2012
111	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 07/2002
99	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2004
91	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 04/2002
82	VaccinesIBA 12/2023 - 04/2002
75	EnzymesIBA 04/2024 - 11/2004
73	LipidsIBA 04/2024 - 11/2006
72	Therapeutic UsesIBA 05/2024 - 07/2003
70	Interleukin-6 (Interleukin 6)IBA 04/2024 - 11/2004
66	Insulin (Novolin)FDA Link 01/2024 - 05/2003
66	Small Interfering RNA (siRNA)IBA 08/2023 - 02/2008
61	Cisplatin (Platino)FDA LinkGeneric 07/2024 - 11/2008
60	AntigensIBA 04/2024 - 03/2002
58	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 02/2009
56	CollagenIBA 05/2024 - 08/2003
55	Peptides (Polypeptides)IBA 04/2024 - 09/2004
52	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2024 - 03/2002
51	Triglycerides (Triacylglycerol)IBA 05/2024 - 07/2003
51	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 02/2003
51	C-Reactive ProteinIBA 01/2024 - 06/2006
46	Transcription Factors (Transcription Factor)IBA 05/2024 - 05/2006
45	Indicators and Reagents (Reagents)IBA 05/2024 - 02/2005
43	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2024 - 02/2008
43	CholesterolIBA 05/2024 - 06/2005
43	CreatinineIBA 04/2024 - 08/2007
43	CateninsIBA 02/2024 - 10/2010
41	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2018
40	Oxygen (Dioxygen)IBA 05/2024 - 08/2006
40	AntioxidantsIBA 04/2024 - 05/2008
39	LipopolysaccharidesIBA 04/2024 - 12/2002
39	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2024 - 07/2003
38	LigandsIBA 01/2024 - 04/2003
37	Blood Glucose (Blood Sugar)IBA 05/2024 - 04/2005
37	Circular RNAIBA 05/2024 - 10/2015
37	AlbuminsIBA 04/2024 - 11/2006
37	InflammasomesIBA 02/2024 - 01/2013
36	AntibodiesIBA 05/2024 - 09/2004
35	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2024 - 02/2011
35	Phosphotransferases (Kinase)IBA 01/2023 - 11/2003

Therapy/Procedure

615	Therapeutics 05/2024 - 03/2002
187	Drug Therapy (Chemotherapy) 07/2024 - 12/2004
85	Immunotherapy 05/2024 - 09/2004
61	Radiotherapy 09/2023 - 12/2004
43	Photochemotherapy (Photodynamic Therapy) 05/2024 - 04/2006
43	Length of Stay 01/2024 - 11/2006
38	Lasers (Laser) 05/2024 - 07/2007
38	Transplantation 02/2024 - 12/2004
33	Aftercare (After-Treatment) 05/2024 - 11/2005